Browsing Tag
Nuvation Bio
2 posts
Why updated TRUST-I and TRUST-II results make IBTROZI a top contender in targeted lung cancer therapy
Nuvation Bio unveils pivotal TRUST-I and TRUST-II updates for IBTROZI in ROS1+ lung cancer, showing strong durability and brain response. Read more now.
September 7, 2025
Nuvation Bio receives FDA clearance for NUV-1511 IND in advanced solid tumors
In a significant stride for cancer treatment, Nuvation Bio Inc. (NYSE: NUVB), a biopharmaceutical company dedicated to addressing…
January 9, 2024